Current and Potential Anticancer Drugs Targeting Members of the UHRF1 Complex Including Epigenetic Modifiers

E-ISSN： 2212-3970|6|1|116-130

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.6, Iss.1, 2011-01, pp. : 116-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiosensitizing Potential of Epigenetic Anticancer Drugs

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 1, 2009-01 ,pp. : 99-108

Bentham Science Publishers

Access to resources Recommend Favorite

UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs

By Jin Wei

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 39-48

Springer Publishing Company

Access to resources Recommend Favorite

UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer

By Jin Wei Chen Li Chen Ying Xu Si-guang Di Gen-hong Yin Wen-jin Wu Jiong Shao Zhi-ming

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 359-373

Springer Publishing Company

Access to resources Recommend Favorite

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

By Sun Yanlin

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 591-599

Springer Publishing Company

Access to resources Recommend Favorite

Marine Derived Anticancer Drugs Targeting Microtubule

Recent Patents on Anti-Cancer Drug Discovery, Vol. 12, Iss. 2, 2017-06 ,pp. : 102-127

Bentham Science Publishers

Access to resources Recommend Favorite